{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:51:26Z","timestamp":1790207486586,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10554-019-01707-5","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T12:03:53Z","timestamp":1570622633000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions"],"prefix":"10.1007","volume":"36","author":[{"given":"Ju-Hyun","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-6968","authenticated-orcid":false,"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Hyung","family":"Doh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"1707_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger RV, Farah A, Ohlow MA et al (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392:849\u2013856. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(18)31719-7","journal-title":"Lancet"},{"key":"1707_CR2","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","volume":"11","author":"Y Tang","year":"2018","unstructured":"Tang Y, Qiao S, Su X et al (2018) Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial. JACC Cardiovasc Interv 11:2381\u20132392. \nhttps:\/\/doi.org\/10.1016\/j.jcin.2018.09.009","journal-title":"JACC Cardiovasc Interv"},{"key":"1707_CR3","doi-asserted-by":"publisher","first-page":"e0147057","DOI":"10.1371\/journal.pone.0147057","volume":"11","author":"SH Ann","year":"2016","unstructured":"Ann SH, Balbir Singh G, Lim KH, Koo BK, Shin ES (2016) Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: serial IVUS-VH and FFR study. PLoS ONE 11:e0147057. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0147057","journal-title":"PLoS ONE"},{"key":"1707_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.rec.2016.03.026","volume":"69","author":"SH Ann","year":"2016","unstructured":"Ann SH, Her AY, Singh GB, Okamura T, Koo BK, Shin ES (2016) Serial morphological and functional assessment of the paclitaxel-coated balloon for de novo lesions. Rev Esp Cardiol (Engl Ed) 69:1026\u20131032. \nhttps:\/\/doi.org\/10.1016\/j.rec.2016.03.026","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"1707_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10554-018-1351-z","volume":"34","author":"AY Her","year":"2018","unstructured":"Her AY, Shin ES, Lee JM, Garg S, Doh JH, Nam CW, Koo BK (2018) Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty. Int J Cardiovasc Imaging 34:1339\u20131347. \nhttps:\/\/doi.org\/10.1007\/s10554-018-1351-z","journal-title":"Int J Cardiovasc Imaging"},{"key":"1707_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ccd.26257","volume":"88","author":"ES Shin","year":"2016","unstructured":"Shin ES, Ann SH, Balbir Singh G, Lim KH, Kleber FX, Koo BK (2016) Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions. Catheter Cardiovasc Interv 88:193\u2013200. \nhttps:\/\/doi.org\/10.1002\/ccd.26257","journal-title":"Catheter Cardiovasc Interv"},{"key":"1707_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/0735-1097(94)90424-3","volume":"23","author":"MD Cerqueira","year":"1994","unstructured":"Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS (1994) Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 23:384\u2013389","journal-title":"J Am Coll Cardiol"},{"key":"1707_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12872-016-0463-4","volume":"17","author":"D Sparv","year":"2017","unstructured":"Sparv D, Gotberg M, Harnek J, Persson T, Madsen Hardig B, Erlinge D (2017) Assessment of increasing intravenous adenosine dose in fractional flow reserve. BMC Cardiovasc Disord 17:60. \nhttps:\/\/doi.org\/10.1186\/s12872-016-0463-4","journal-title":"BMC Cardiovasc Disord"},{"key":"1707_CR9","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","volume":"376","author":"JE Davies","year":"2017","unstructured":"Davies JE, Sen S, Dehbi HM et al (2017) Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 376:1824\u20131834. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1700445","journal-title":"N Engl J Med"},{"key":"1707_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","volume":"376","author":"M Gotberg","year":"2017","unstructured":"Gotberg M, Christiansen EH, Gudmundsdottir IJ et al (2017) Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 376:1813\u20131823. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1616540","journal-title":"N Engl J Med"},{"key":"1707_CR11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.jacc.2017.09.007","volume":"70","author":"JM Lee","year":"2017","unstructured":"Lee JM, Park J, Hwang D et al (2017) Similarity and difference of resting distal to aortic coronary pressure and instantaneous wave-free ratio. J Am Coll Cardiol 70:2114\u20132123. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2017.09.007","journal-title":"J Am Coll Cardiol"},{"key":"1707_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ahj.2014.06.022","volume":"168","author":"R Petraco","year":"2014","unstructured":"Petraco R, Al-Lamee R, Gotberg M et al (2014) Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J 168:739\u2013748. \nhttps:\/\/doi.org\/10.1016\/j.ahj.2014.06.022","journal-title":"Am Heart J"},{"key":"1707_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","volume":"102","author":"FX Kleber","year":"2013","unstructured":"Kleber FX, Rittger H, Bonaventura K et al (2013) Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 102:785\u2013797. \nhttps:\/\/doi.org\/10.1007\/s00392-013-0609-7","journal-title":"Clin Res Cardiol"},{"key":"1707_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/heartjnl-2014-305986","volume":"100","author":"ES Shin","year":"2014","unstructured":"Shin ES, Lee JH, Yoo SY et al (2014) A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. Heart 100:1531\u20131536. \nhttps:\/\/doi.org\/10.1136\/heartjnl-2014-305986","journal-title":"Heart"},{"key":"1707_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","volume":"60","author":"J Wohrle","year":"2012","unstructured":"Wohrle J, Zadura M, Mobius-Winkler S et al (2012) SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 60:1733\u20131738. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2012.07.040","journal-title":"J Am Coll Cardiol"},{"key":"1707_CR16","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/circulationaha.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351. \nhttps:\/\/doi.org\/10.1161\/circulationaha.106.685313","journal-title":"Circulation"},{"key":"1707_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","volume":"105","author":"FX Kleber","year":"2016","unstructured":"Kleber FX, Rittger H, Ludwig J, Schulz A, Mathey DG, Boxberger M, Degenhardt R, Scheller B, Strasser RH (2016) Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 105:613\u2013621. \nhttps:\/\/doi.org\/10.1007\/s00392-015-0957-6","journal-title":"Clin Res Cardiol"},{"key":"1707_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijcard.2016.09.105","volume":"225","author":"PJ Koln","year":"2016","unstructured":"Koln PJ, Scheller B, Liew HB et al (2016) Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting: a feasibility and safety study. Int J Cardiol 225:262\u2013267. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2016.09.105","journal-title":"Int J Cardiol"},{"key":"1707_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/01.CIR.99.7.883","volume":"99","author":"GJ Bech","year":"1999","unstructured":"Bech GJ, Pijls NH, De Bruyne B, Peels KH, Michels HR, Bonnier HJ, Koolen JJ (1999) Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 99:883\u2013888","journal-title":"Circulation"},{"key":"1707_CR20","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1161\/01.Cir.0000061950.24940.88","volume":"107","author":"B De Bruyne","year":"2003","unstructured":"De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR (2003) Intracoronary and intravenous adenosine 5\u2032-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107:1877\u20131883. \nhttps:\/\/doi.org\/10.1161\/01.Cir.0000061950.24940.88","journal-title":"Circulation"},{"key":"1707_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/(sici)1097-0304(199610)39:2<120::Aid-ccd3>3.0.Co;2-h","volume":"39","author":"PH van der Voort","year":"1996","unstructured":"van der Voort PH, van Hagen E, Hendrix G, van Gelder B, Bech JW, Pijls NH (1996) Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 39:120\u2013125. \nhttps:\/\/doi.org\/10.1002\/(sici)1097-0304(199610)39:2%3c120:Aid-ccd3%3e3.0.Co;2-h","journal-title":"Cathet Cardiovasc Diagn"},{"key":"1707_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jcin.2011.08.007","volume":"4","author":"NH Pijls","year":"2011","unstructured":"Pijls NH, Tonino PA (2011) The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve. JACC Cardiovasc Interv 4:1093\u20131095. \nhttps:\/\/doi.org\/10.1016\/j.jcin.2011.08.007","journal-title":"JACC Cardiovasc Interv"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01707-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-019-01707-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01707-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T23:16:49Z","timestamp":1602112609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-019-01707-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1007\/s10554-019-01707-5","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]},"assertion":[{"value":"6 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}